Markets are very kind to Electronic Components with Inds P/E at 84x, here’s a API manf doing PCB assembly for glucometers (own brand) potential to expand into various other medical equips, currently at sub 30x P/E.
Apart from corporate governance issue in past, where am I reading this incorrectly, kindly guide.
Subscribe To Our Free Newsletter |